Blood Tests for Female Fertility Assessment
The most important blood tests for assessing female fertility include luteinizing hormone (LH), follicle-stimulating hormone (FSH), estradiol, and anti-Müllerian hormone (AMH), which together provide critical information about ovarian function and reserve. 1
Primary Blood Tests for Fertility Assessment
Ovarian Reserve Testing
Anti-Müllerian Hormone (AMH)
- Gold standard for assessing ovarian reserve
- Correlates with antral follicle count and predicts ovarian response
- Advantages: minimal variation throughout menstrual cycle, not affected by hormonal contraceptives 2
- Low AMH suggests diminished ovarian reserve but doesn't predict oocyte quality or pregnancy chances
Follicle-Stimulating Hormone (FSH)
- Should be measured on cycle day 3
- Elevated levels (>10 mIU/mL) suggest diminished ovarian reserve
- Inversely correlated with AMH levels 3
- An FSH level of 12.1 mIU/mL correlates with an AMH of approximately 0.5 ng/mL
Estradiol
Ovulatory Function Testing
- Luteinizing Hormone (LH)
- Helps assess ovulatory function
- LH:FSH ratio >2:1 may suggest polycystic ovarian syndrome
- Best measured on day 1-3 of menstrual cycle 4
Secondary Blood Tests
Thyroid Function Tests
- TSH to screen for thyroid dysfunction
- Thyroid abnormalities can impair fertility and increase pregnancy complications 1
Prolactin
- Elevated levels can inhibit ovulation
- Important when irregular menses or galactorrhea are present 1
Androgens (Testosterone, DHEAS)
- Indicated when clinical signs of androgen excess are present
- Helps diagnose PCOS and other causes of anovulation 1
Special Considerations
Timing of Tests
- FSH, LH, and estradiol should be measured on cycle days 1-4 (ideally day 3)
- AMH can be measured at any point in the cycle 2
Interpretation Challenges
- AMH levels must be interpreted in context of age and clinical presentation
- Low AMH in young women with normal menstrual cycles may not indicate immediate fertility problems
- FSH values may fluctuate between cycles; consider repeating abnormal results 1
Risk Factors Requiring Earlier or More Comprehensive Testing
- Age >35 years
- History of chemotherapy or radiation
- Previous ovarian surgery
- Family history of early menopause
- Smoking history 1
Clinical Application Algorithm
- Initial Screening: AMH, FSH, LH, estradiol on cycle day 3
- If abnormal FSH/LH: Add thyroid function tests and prolactin
- If signs of androgen excess: Add testosterone and DHEAS
- If abnormal results: Consider transvaginal ultrasound for antral follicle count 1
Common Pitfalls
- Relying solely on AMH as a "fertility test" - it reflects quantity not quality of eggs
- Testing FSH on incorrect cycle day
- Failing to consider age as the strongest predictor of fertility
- Not repeating abnormal results before making clinical decisions 2
Blood tests provide valuable information about fertility potential but should be interpreted alongside imaging studies and clinical presentation for comprehensive fertility assessment.